Previous Article | Next Article ![]()
Molecular and Cellular Biology, February 1999, p. 1313-1324, Vol. 19, No. 2
Department of Biochemistry & Molecular
Biophysics1 and
Herbert Irving
Comprehensive Cancer Center,2 College of
Physicians & Surgeons, Columbia University, New York, New York 10032, and
Department of Biological Sciences, Columbia
University, New York, New York 100273
Received 8 May 1998/Returned for modification 1 July 1998/Accepted 3 November 1998
Protein kinase C (PKC) is a multigene family of enzymes consisting
of at least 11 isoforms. It has been implicated in the induction of
c-fos and other immediate response genes by various mitogens. The serum response element (SRE) in the c-fos
promoter is necessary and sufficient for induction of transcription of c-fos by serum, growth factors, and the phorbol ester
12-O-tetradecanoylphorbol-13-acetate (TPA). It forms a
complex with the ternary complex factor (TCF) and with a dimer of the
serum response factor (SRF). TCF is the target of several signal
transduction pathways and SRF is the target of the rhoA pathway. In
this study we generated dominant-negative and constitutively active
mutants of PKC-
0270-7306/99/$04.00+0
Copyright © 1999, American Society for Microbiology. All rights reserved.
Novel Roles of Specific Isoforms of Protein Kinase
C in Activation of the c-fos Serum Response
Element
, PKC-
, PKC-
, and PKC-
to determine the
roles of individual isoforms of PKC in activation of the SRE.
Transient-transfection assays with NIH 3T3 cells, using an SRE-driven
luciferase reporter plasmid, indicated that PKC-
and PKC-
, but
not PKC-
or PKC-
, mediate SRE activation. TPA-induced activation
of the SRE was partially inhibited by dominant negative c-Raf, ERK1, or
ERK2, and constitutively active mutants of PKC-
and PKC-
activated the transactivation domain of Elk-1. TPA-induced activation
of the SRE was also partially inhibited by a dominant-negative MEKK1.
Furthermore, TPA treatment of serum-starved NIH 3T3 cells led to
phosphorylation of SEK1, and constitutively active mutants of PKC-
and PKC-
activated the transactivation domain of c-Jun, a major
substrate of JNK. Constitutively active mutants of PKC-
and PKC-
could also induce a mutant c-fos promoter which lacks the
TCF binding site, and they also induce transactivation activity of the
SRF. Furthermore, rhoA-mediated SRE activation was blocked by dominant
negative mutants of PKC-
or PKC-
. Taken together, these findings
indicate that PKC-
and PKC-
can enhance the activities of at
least three signaling pathways that converge on the SRE:
c-Raf-MEK1-ERK-TCF, MEKK1-SEK1-JNK-TCF, and rhoA-SRF. Thus, specific
isoforms of PKC may play a role in integrating networks of signal
transduction pathways that control gene expression.
*
Corresponding author. Mailing address: Herbert Irving
Comprehensive Cancer Center, HHSC-1509, 701 West, 168th St., New
York, NY 10032. Phone: (212) 305-6924. Fax: (212) 305-6889. E-mail: weinstein{at}cuccfa.ccc.columbia.edu.
This article has been cited by other articles:
| J. Bacteriol. | J. Virol. | Eukaryot. Cell |
|---|
| Microbiol. Mol. Biol. Rev. | Clin. Vaccine Immunol. | All ASM Journals |
|---|